Mechanisms contributing to increased cardiovascular risk in patients taking proton pump inhibitors. [Cartal] (2017)
- Authors:
- USP affiliated author: SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- School: FMRP
- DOI: 10.1111/nmo.12988
- Subjects: DOENÇAS VASCULARES; FARMACOLOGIA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Neurogastroenterology & Motility
- ISSN: 1350-1925
- Volume/Número/Paginação/Ano: v. 29, n. 2, art. e12988, 2017
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
AMARAL, Jefferson Henrich e TANUS-SANTOS, José Eduardo. Mechanisms contributing to increased cardiovascular risk in patients taking proton pump inhibitors. [Cartal]. Neurogastroenterology & Motility. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: http://dx.doi.org/10.1111/nmo.12988. Acesso em: 02 jul. 2022. , 2017 -
APA
Amaral, J. H., & Tanus-Santos, J. E. (2017). Mechanisms contributing to increased cardiovascular risk in patients taking proton pump inhibitors. [Cartal]. Neurogastroenterology & Motility. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1111/nmo.12988 -
NLM
Amaral JH, Tanus-Santos JE. Mechanisms contributing to increased cardiovascular risk in patients taking proton pump inhibitors. [Cartal] [Internet]. Neurogastroenterology & Motility. 2017 ; 29( 2):[citado 2022 jul. 02 ] Available from: http://dx.doi.org/10.1111/nmo.12988 -
Vancouver
Amaral JH, Tanus-Santos JE. Mechanisms contributing to increased cardiovascular risk in patients taking proton pump inhibitors. [Cartal] [Internet]. Neurogastroenterology & Motility. 2017 ; 29( 2):[citado 2022 jul. 02 ] Available from: http://dx.doi.org/10.1111/nmo.12988 - Atorvastatina reduz a hipertensão arterial pulmonar causada por embolia pulmonar aguda (EPA) em ratos
- Chronic antihypertensive effects of sodium nitrite in L-name-induced hypertension in rats
- eNos haplotype associated with hypertension in obese children and adolescents
- Pharmacogenetic relevance of endothelial nitric oxide synthase polymorphisms and gene interactions
- Lack of association between genetic polymorphism of FTO, AKT1 and AKTIP in childhood overweight and obesity
- Sodium nitrite does not inhibit circulating angiotensin converting enzyme activity
- Matrix metalloproteinase-9 genetic variation affect MMP-9 levels in obese children
- Sildenafil improves the beneficial hemodynamic effects exerted by atorvastatin during acute pulmonary thromboembolism
- Matrix metalloproteinases as drug targets in preeclampsia
- Quercetin restores plasma nitrite and nitroso species levels in renovascular hypertension
Informações sobre o DOI: 10.1111/nmo.12988 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
